At the moment, treatment of congenital ichthyosis relies on topical ... the first FDA-approved therapy for idiopathic macular telangiectasia type 2.

Encelto, the first FDA-approved treatment for MacTel, is implanted intravitreally during a surgery performed by a qualified ophthalmologist. The Food and Drug Administration (FDA) has approved ...

Revakinagene taroretcel-lwey (Encelto; Neurotech), an allogeneic encapsulated cell-based gene therapy, is the first therapy to be approved for macular telangiectasia type 2. The FDA approved ...

2 Beijing Key Laboratory for Genetic Research of Skeletal Deformity, Beijing, China Background Brain arteriovenous malformations (BAVM) represent a congenital anomaly of the cerebral vessels with a ...

In particular, the scientists believe that the atlas could be important for the study of genes that cause congenital hair ... therapy for idiopathic macular telangiectasia type 2.